Leqembi® (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MCD
7. MGM
8. NVDA
9. AKAM
10. ACAD

Go back to Leqembi® (lecanemab) Authorized for Early Alzheimer's Disease in Great Britain
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 226.36 --0 (-0%)
Previous Close $226.36    52 Week High $333.65 
Open $226.36    52 Week Low $223.02 
Day High $226.36    P/E 28.98 
Day Low $226.36    EPS $7.81 
Volume 16